Please enter the contact details of the person submitting the abstract. Please note that all initial correspondence will be with the submitter of the abstract. This cannot be changed at a later date so please do ensure that the person submitting is able to remain as the main contact throughout the submission and acceptance process. Please note that the person submitting the abstract is the only one who can view and amend the abstract in the submission system.

Your suggested title should be succinct yet clearly describe the abstract. Use sentence case (i.e. the first letter of the sentence is capitalised, with the rest being lowercase except for proper nouns and acronyms). Do not use any abbreviations in the title. The titles of accepted abstracts will be published in the final conference programme and on the conference app. (Maximum 160 characters)

Please declare any potential conflicts of interest, financial or otherwise that may influence, or could be perceived to influence the content of your abstract. This includes, but is not limited to, financial relationships, affiliations, sponsorships, or personal interests related to the subject matter of your submission.

Please confirm your agreement to the following statement, in order for your abstract to be considered for presentation:

“I have read and agree to follow the relevant abstract submission guidelines and will take responsibility for managing my submission. This includes acknowledging the review outcome, registering the presenting author, and preparing the required material, either a physical poster or, if selected, a physical poster and accompanying short oral presentation. I understand that to accept the invitation to present at the event, one named author must register at the appropriate two-day ticket rate (based on their professional status on the first day of the event) to present the abstract. I also accept that it is my responsibility to ensure the presenting author is not presenting more than one poster at this event.”

The submitter will be required to indicate the preferred presentation format when submitting an abstract. The two options are physical poster only or physical poster and oralpresentation. The final decision on allocations will be made by the programme committee.

Physical posters

All accepted abstracts will be presented as A0 physical posters, displayed in person at the conference in Birmingham on both days - Monday 20 April and Tuesday 21 April 2026. Posters will be displayed in the Exhibition Hall, where authors should be available to discuss their work during the breaks.

Oral presentation and physical poster

A small number of abstracts will also be selected for a short oral presentation, in addition to being displayed as physical posters. Oral presentations will take place in the Mini Theatres located within the Exhibition Hall, on either Monday 20 April or Tuesday 21 April 2026. If selected, presenters will be asked to prepare a short slide deck containing a maximum of two slides and deliver a 5-minute presentation (3 minutes to present, followed by 2 minutes for Q&A).

Please note that there is no option for oral presentation only.

Please enter the main author and any co-authors associated with this abstract. Co-authors are not mandatory, but please ensure you add all authors at the time of submission as it will not be possible to add authors at a later stage.

You will be required to enter the co-author’s details, so ensure you have these details ready:

• Title, first name, last name, organisation, job title, email address.
• You must ensure that you have gained the full consent of any co-authors and have made them aware prior to adding their details to the submission.
• Please note you can list a maximum of 10 co-authors on your submission.

Your abstract should not exceed 350 words.There is an additional 150 word allowance for references.

General style guidelines

• Use standard abbreviations only and place any unusual abbreviation in parentheses after the full word the first time it appears
• Use generic names of drugs
• If reference is made to proprietary products or equipment, the manufacturer's name and location should be included in parentheses
• Please check your abstract carefully as it cannot be amended at a later date
• Graphs, tables and images can be inserted. All images, symbols, tables, graphs and lines should be clear and distinct. Maximum file size 10MB
• You may add one table and one graph to your submission. Graphs and tables are not included in the word count. Your submission should include a reference to the provided table and graph

The structure of your abstract

• Each section of your abstract should provide essential information about your study, allowing readers to quickly understand its scope and significance.
• We accept two types of abstracts: Research abstracts and case studies / case reports.
• Because these have different purposes, they require different structures. Please follow the guidelines below according to your submission type.

Research abstracts should be structured under the headings:

• Background: Clearly state the purpose of the abstract and why the topic is important
• Methods: Describe your selection of observations or experimental subjects clearly
• Results: Present your results in a logical sequence in text and simple tables - if results are not included, your abstract will not be considered
• Conclusion: Clearly state the conclusion of your abstract

Case studies / case reports should be structured under the headings:

• Background: Clearly state the purpose of the abstract and why the topic is important
• Case presentation: Describe the patient in detail, including history and presenting symptoms, examination findings, investigations, diagnosis, treatment or intervention, and outcome
• Discussion: Analyse the case in relation to existing literature, highlighting the significance of the findings, what makes it unique or relevant, and the key clinical considerations
• Conclusion: Clearly state the conclusion of your abstract